Harvard Health Blog

Following low-risk prostate cancers before starting treatment becoming more common

Posted September 23, 2015, 8:43 am, Updated September 24, 2015, 8:03 am Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Disease Men who have slow growing, low-risk prostate cancer may not live long enough to die of their illness. And since there’s no conclusive evidence that treating low risk prostate cancer extends survival, doctors might recommend monitoring the cancer and treating it only when it begins to spread. …

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In